August 2018 - Page 2 of 2 - Buhlmann Diagnostics Corp

Month: August 2018

Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort

BÜHLMANN MRP8/14 ELISA: García-Arias M et al.: Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Molecular Diagnosis and Therapy. 2013: 17(1):49-56.  PMID: 23329363 DOI: 10.1007/s40291-013-0016-9 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Can mHealth Apps replace clinic visits?

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a recent article in the Journal of mHealth (Volume 3, Issue 3), McCombie and colleagues performed a systematic review of IBD symptom monitoring smartphone apps. Highlight from this Article In this study, 233 separate apps were found on
Continue Reading

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a recent interview with Lead Inflammatory Bowel Disease Nurse, Pearl Avery, conducted by BÜHLMANN's UK distributor Alpha Laboratories: Highlight from this Article “In the six months that we have been working with the IBDoc, one patient was
Continue Reading

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis

BÜHLMANN sCAL ELISA: Andrés Cerezo et al.: Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Research and Therapy. 2011; 13(4).  PMID: 21791097  DOI: 10.1186/ar3426 . Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in
Continue Reading

BUHLMANN LabSense News Summer 2018 Edition

In this "Summer Edition" we are pleased to announce the FDA 510 (k) clearance of the BÜHLMANN fCAL® ELISA. We make mention of upcoming meetings where you can find us such as American Association of Clinical Chemistry (AACC) and the Association of Medical Laboratory Immunologists (AMLI) annual meetings. Additionally, we share the exciting happenings pertaining to
Continue Reading